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Identification of hNopp140 as a Binding Partner
for Doxorubicin with a Phage Display Cloning Method
utes to its cytotoxicity [9–11] and that the interaction of
doxorubicin with an extracelluar component(s) induces
a toxic effect [12–14]. Together, these observations im-
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Korea Institute of Science and Technology ply that doxorubicin could interact with a variety of cellu-
lar components, some of which may be the targets forP.O. Box 131
Cheongryang, Seoul 130-650 its anticancer activity.
Methods to identify proteins that interact with a spe-Korea
cific ligand are limited. An affinity selection method in
which the target proteins are purified from cell extracts
by the use of ligand-immobilized beads has been de-Summary
scribed. FKBP12 (FK506 binding protein) is an example
that was isolated from a whole-cell extract by the useDoxorubicin is a widely used anti-cancer drug. It is
of immobilized FK506 on resin beads [15]. Biopanningassumed to act by inhibiting DNA replication or tran-
by using a phage display library provides anotherscription, although its precise targets and mechanism
method for the identification of the target proteins toof cytotoxicity remain unresolved. A T7 phage library
specific ligands. Random sequences of hepta- or do-expressing human liver cDNA was screened against
decameric peptides [16, 17] or cDNA from human tissueimmobilized doxorubicin to isolate doxorubicin bind-
[18, 19] can be displayed on the surface of phage parti-ing proteins. The selected phage contained the C-ter-
cles. Such phage libraries have been used successfullyminal region of nucleolar phosphoprotein hNopp140,
to identify proteins that specifically bind to immobilizedan important factor in the biogenesis of the nucleolus.
taxol [20] or FK506 [21].When the cloned sequence was expressed in E. coli,
This study has identified a doxorubicin-interactingthe recombinant protein was phosphorylated by ca-
protein by using a phage library displaying human liversein kinase II and oligomerized in the presence of mag-
cDNA. A phage clone expressing the C-terminal domainnesium and fluoride ions, as occurs in vivo. Doxorubi-
of human nucleolar phosphoprotein, hNopp140, was se-cin bound to the expressed protein with a dissociation
lectively amplified during the biopanning procedure.constant of 4.5  106 M, and this interaction was
Furthermore, the expressed protein showed specificinhibited by the phosphorylation of hNopp140. These
binding to doxorubicin in a phosphorylation-dependentresults suggested that doxorubicin might disrupt the
manner.cellular function of hNopp140.
Results
Introduction
Doxorubicin-Specific Phage Was Amplified
Doxorubicin is one of the anthracycline antibiotics iso- by Biopanning
lated from Streptomyces. It is composed of an anthracy- A T7 phage library displaying human liver cDNA was
cline ring linked via a glycosidic bond to an amino sugar. screened for proteins binding specifically to the biotinyl-
It is an antineoplastic agent used for the treatment of ated doxorubicin (Figure 1) on a streptavidin-coated
acute leukemia and a wide variety of solid tumors [1], plate. The phage titer of the eluted solutions increased
although it has been associated with severe side effects from 103 pfu/ml after the first round to 105 pfu/ml at
such as nausea, local necrosis, anorexia, and alopecia the fourth round of binding and elution (Figure 2A). To
[2, 3]. The four fused-ring structure of doxorubicin confirm the enrichment of specific phage particles,
pointed to its major target as being chromosomal DNA, cDNAs inserted into the eluted phages were analyzed
where it intercalates between the base pairs. Doxorubi- by PCR with primers flanking the library construction
cin can bind to supercoiled plasmid DNA or calf thymus site of the T7 phage DNA. The phage PCR products
DNA with dissociation constants in the 105 M range from the first round of elution appeared as smear bands
[4]. The intercalation would hinder DNA replication or (Figure 2B, lane 1). The PCR products of the eluted
transcription [5, 6] and also affect the activity of DNA- phages from the second-, third-, and fourth-round am-
modifying enzymes, including topoisomerase [7]. plifications (Figure 2B, lanes 2, 3, and 4), however, re-
Although the DNA binding appears to be critical for the vealed bands of 600 and 870 bp. These results indicated
anticancer activity of doxorubicin, the detailed cytotoxic that doxorubicin-specific phages were selectively am-
mechanism of its action is not yet fully understood. plified by the biopanning procedure.
There have been reports of doxorubicin interacting with
cellular components other than DNA. The activity of RNA Sequence Analysis of Doxorubicin-Specific
polymerase II with either denatured or native DNA as Phage Clone
a template was inhibited with similar sensitivities by DNA sequences were determined for 20 phages eluted
doxorubicin [8]. It has been reported also that the gener- and selected from the fourth and final round of biopan-
ation of active oxygen species from doxorubicin contrib- ning. Two of the isolated clones had a PCR product of
870 bp and had an insert of 648 bp that produced an
open reading frame of 216 amino acids. The other 183 Correspondence: ygy@kist.re.kr
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Figure 1. Structure of Doxorubicin and Bio-
tinylated Doxorubicin
The amine group of doxorubicin was coupled
with NHS-biotin to produce biotinylated dox-
orubicin.
clones had PCR products of about 600–700 bp. How- PAGE (Figure 3A, lanes 1 and 2) and urea gels (Figure
3C, lanes 1 and 2). In contrast, the protein treated withever, the ORFs from these clones consisted of less than
20 amino acids. These clones represented background casein kinase II migrated more slowly than the native
form in SDS-gels (Figure 3A, lane 3) and was radio-binders, and they were not further analyzed. The se-
quence of the ORF of 216 amino acids was identical to labeled by 32P ATP in a phosphorylation reaction (Figure
3B). The phosphorylated form migrated more quicklythe C-terminal region (amino acids 388–603 out of 699
residues) of human nucleolar phosphoprotein, hNopp140. than the native form in urea-denaturaing gels because
of the increased negative charge (Figure 3C, lane 3).When the phage plaques from each round of elution
were hybridized with the cloned DNA as a probe, the These results indicate that the recombinant hNopp140
protein was comparable in conformation to the nativephage containing the hNopp140 sequence was enriched
during the biopanning procedure (data not shown). form since both can be similarly phosphorylated by ca-
sein kinase II.
It has been shown that hNopp140 aggregates to anExpression and Characterization of the
C-Terminal Region of hNopp140 insoluble form in the presence F and Mg2 ions [23].
To examine the involvement of the cloned C-terminalThe cloned sequence of hNopp140 was expressed and
purified to examine its interaction with doxorubicin. It region of hNopp140 in the aggregation, we tested the
solubility of Trx-hNopp140C in the presence of NaFwas inserted at the C terminus of thioredoxin, and the
fusion protein (Trx-hNopp140C) was overexpressed in and MgCl2 salts. The unphosphorylated form of Trx-
hNopp140C was not aggregated (Figure 4, lane 1 andE. coli in a soluble form. The protein was further purified
by Ni affinity and hydroxylapatite columns (Figure 3A, 2). In contrast, most of the phosphorylated protein was
aggregated and insoluble (Figure 4, lanes 3 and 4). Theselane 1). The protein hNopp140 has more than 80 poten-
tial phosphorylation sites and is highly phosphorylated results indicate that the cloned region of hNopp140 is
responsible for the salt-dependent oligomerization andby casein kinase II [22]. When the purified Trx-
hNopp140C was treated with calf intestine phospha- that this phenomenon is negatively controlled by phos-
phorylation.tase, it comigrated with the untreated protein in SDS-
Figure 2. Analysis of Phages Eluted after
Each Round of Biopanning
(A) The phage titer was determined for each
washing and eluted solution at each round.
(B) The insert size of the phage DNA from the
whole eluted phage sample at each round
was analyzed by polymerase chain reaction
(PCR) with primers flanking the insertion
sites. The PCR products from the first-, sec-
ond-, third-, and fourth-round elutions were
loaded in lanes 1, 2, 3, and 4, respectively,
along with marker DNA (lane M).
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lated hNopp140C. When Trx-hNopp140C was applied
to immobilized doxorubicin on the CM5 surface plasmon
resonance sensor chip, a strong binding curve was ob-
served (Figure 6). The apparent dissociation constant
(Kd) of Trx-hNopp140C binding to doxorubicin was cal-
culated as 4.5 106 M. As in the fluorescence measure-
ment experiment, the phosphorylated form of Trx-
hNopp140C failed to bind doxorubicin. When the 650
bp DNA fragment (100 nM) was applied to the chip sur-
face, no significant adsorption curve was observed.
These results imply that doxorubicin binds specifically
to the nonphosphorylated form of hNopp140, with a
higher binding affinity than for DNA.
Figure 3. Phosphorylation of the Purified Trx-hNopp140C
(A) The native form of Trx-hNopp140C (lane 1), along with the de- Discussion
phosphorylated (lane 2) and phosphorylated (lane 3) forms, was
analyzed by 12% SDS-gel electrophoresis.
Different phage libraries have been developed to display(B) When 32P-d-ATP was used in the phosphorylation reaction, Trx-
short peptides of 7–12 amino acids [16, 17, 24] as wellhNopp140C was labeled with 32P.
(C) Dephosphorylated (lane 1), native (lane 2), and phosphorylated as larger proteins up to 40 kDa [25] as fusion proteins
forms (lane 3) of Trx-hNopp140C were analyzed by 8% Urea-PAGE. of the P3 or P8 M13 phage coat protein. In addition, the
The marked band in lane 2 of panel (A) and in lane 1 of panel (C) p10 coat protein of the T7 phage was used to display
was calf intestine phosphatase (dephosphorylating enzyme).
proteins up to 1000 amino acids. Biopanning with these
phage display libraries has been used to identify peptide
motifs that bind specifically to a particular receptor [26,Direct Measurement of the Binding between
27], enzyme [28, 29], or even RNA [30]. In addition, theDoxorubicin and Trx-hNopp140C
p10 coat protein of the T7 phage was used to displayThe interaction between doxorubicin and Trx-
proteins up to 1000 amino acids, and such a displayhNopp140C was analyzed by fluorescence spectrome-
library has been successfully used for the identificationtry and surface plasmon resonance analysis. Doxorubi-
of proteins that interact with specific protein or syntheticcin had an emission spectrum of 530–600 nm with a
peptides [31]. This method was also applied to identifypeak at 555 nm. The addition of the recombinant Trx-
small-molecule interactors, such as FK506 or taxol [20,hNopp140C protein in a dose-dependent manner signifi-
21]. In this study, a C-terminal region of hNopp140 wascantly increased the emission intensity, although the
selected and identified as an interacting protein of doxo-shape of spectrum was almost unchanged (Figure 5).
rubicin by the biopanning procedure from the T7 phageBSA or thioredoxin, however, had no effect on the fluo-
display library displaying human liver cDNA. The ex-rescence spectrum (data not shown). Interestingly,
pressed C-terminal region of hNopp140 showed strongphosphorylated Trx-hNopp140C also had no effect on
binding affinity for doxorubicin, with an apparent disso-the fluorescence spectrum of doxorubicin, suggesting
ciation constant in the M range.that doxorubicin could interact only with dephosphory-
The ring moiety in doxorubicin comprises the proba-
ble binding motif for hNopp140 since the sugar group
was used for immobilization. This was supported by the
increased fluorescence intensity of doxorubicin in the
presence of hNopp140. Since the fluorescent chromo-
phore is the ring moiety, the change of fluorescence
indicated that hNopp140 directly contacted the ring
group and might contribute to the dequenching effect.
The affinity of doxorubicin for hNopp140 appeared to
be stronger than its affinity for DNA. The reported disso-
ciation constant for doxorubicin/DNA binding (about
10–20 M; [4]) is 2- to 5-fold higher than the observed
value for the binding of immobilized doxorubicin and
Trx-hNopp140C in this study. Furthermore, a double-
stranded DNA fragment failed to show any significant
binding to the immobilized doxorubicin in our BIAcore
study (Figure 5). The 3 amino group of doxorubicin
Figure 4. Phosphorylation-Dependent Aggregation of Trx- participates in the interaction with DNA [32] and forms
hNopp140C a covalent link with the 2-amino group in guanine [33].
The formation of insoluble aggregates of Trx-hNopp140C was exam- Hence, the failure of the DNA to associate with the immo-
ined after incubation with 25 mM each of NaF and MgCl2 at 4C for bilized doxorubicin in these experiments might be due
1 hr. Native (lane 1 and 2) or phosphorylated Trx-hNopp140C (lanes
to the lack of the free 3 amino group on doxorubicin.3 and 4) was incubated in the presence (lanes 2 and 4) or absence
The specific binding between doxorubicin and(lanes 1 and 3) of NaF and MgCl2, and the soluble fraction was
analyzed by 12% SDS-PAGE. hNopp140 suggests that the drug might interact prefer-
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Figure 5. Fluorescence Spectra of Doxorubi-
cin and Trx-P140C/Doxorubicin Complex
The fluorescence spectrum of 0.7 M doxo-
rubicin alone (bold line) in 10 mM Mops buffer
containing 150 mM NaCl and 0.5 mM EDTA
(pH 7.5) was compared with the spectrum of
doxorubicin in the presence of 10 M native
(thin line) or phosphorylated forms of Trx-
hNopp140C (dotted line). The excitation wave-
length was 490 nm, and the emission spec-
trum was obtained between 530 and 600 nm.
entially with hNopp140 after in vivo administration and further phosphorylated [22]. Specific binding of doxoru-
bicin to nonphosphorylated hNopp140 would affect thethereby affect the cellular function of hNopp140. Pre-
viously, mouse Nopp140 was known to be located at the cellular function of hNopp140, such as in ribosomal as-
sembly or transcription of rDNA, and severely affect thenucleolus, and it was assumed to be a key component in
the biogenesis of nucleoli [22]. It was also shown to normal operation of the cell cycle.
interact with proteins involved in the transcription of
rDNA; such proteins included RNA polymerase I [34], Conclusions and Future Work
We have cloned the C-terminal domain of hNopp140 asC/EBP [35], and casein kinase II [36]. hNopp140 was
identified as one of the most highly phosphorylated pro- a doxorubicin binding protein by using a phage display
cloning method. Fluorescence spectrometry confirmedteins and possessed ATPase/GTPase activity [23]. Over-
expression of the partial or whole hNopp140 cDNA re- that the expressed protein binds to doxorubicin, and
we used surface plasmon resonance to measure a dis-sulted in mislocalization of nucleolar proteins, improper
formation of the nucleolus, and inhibition of rRNA gene sociation constant. Furthermore, it was shown that the
only the unphosphorylated form of hNopp140 wastranscription [34, 37].
It should be noted that the cell cycle stage at which bound. From these results, it can be implied that doxoru-
bicin affects the cellular function of hNopp140. Sincedoxorubicin has an effect is synchronous to a stage
when the expression of hNopp140 is reduced. Doxorubi- hNopp140 plays a critical role in the rDNA transcription
and the biogenesis of nucleolus, the binding of doxoru-cin has been known to arrest the cell cycle at the G2/M
phase. hNopp140 levels are decreased during mitosis, bicin to hNopp140 would severely affect cell growth. A
detailed analysis of the localization, cellular levels, andand the remaining hNopp140 in mitotic cells can be
Figure 6. The Binding Sensorgram of the
C-Terminal Region of hNopp140 on Doxoru-
bicin
Sensorgrams were obtained for 62.5 nM (thin
line), 1 M (dotted line), and 2 M (bold line)
of Trx-hNopp140C, 4 M of phosphorylated
Trx-hNopp140C (broken line), and 100 nM of
DNA (bold broken line) against doxorubicin
immobilized on the sensor chip.
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hNopp140 sequence at the C terminus was expressed after induc-possible conformational alterations to hNopp140 in
tion by 1 mM IPTG. The harvested E. coli cells were lysed with adoxorubicin-treated cells would elucidate the relation-
French Pressor, and cell debris was removed by centrifugation atship between hNopp140 and the anti-cancer drug doxo-
15,000  g for 20 min. The crude extract was loaded onto an Ni-
rubicin and contribute to a better understanding of the NTA column, and the bound proteins were eluted with 200 mM of
mechanism of this drug’s cytotoxicity. imidazole solution (pH 7.0). The eluted proteins were dialyzed
against 10 mM Mops [3-(N-morpholino) propanesulfonic acid] buffer
(pH 7.5) and loaded onto a hydroxylapatite column. Proteins wereSignificance
eluted with a gradient of 300 ml of 20–300 mM sodium phosphate (pH
7.5). The eluted proteins were pooled, concentrated, and dialyzed
Display cloning has been developed for use with affin- against 10 mM MOPS buffer.
ity selection methods to identify the cellular targets
of bioactive compounds. The specific interaction dem- Protein Phosphorylation
Proteins were phosphorylated by mixing 5 g of substrate proteinonstrated between the protein isolated from the hu-
with 50 U of casein kinase II (New England BioLabs) in 20 l ofman cDNA phage library and doxorubicin illustrates
kinase reaction buffer (20 mM Tris-HCl [pH 7.5], 50 mM KCl, 10 mMthat this approach is effective for the identification of
MgCl2, and 2.5 mM ATP) at 30C for 2 hr. Dephosphorylation wastherapeutic targets as well as bioactive natural com- performed by incubation of 5 g of substrate protein with 5 U of
pounds. calf intestine alkaline phosphatase (New England BioLabs) in 20 l
of the reaction solution containing 5 mM Tris-HCl (pH 7.9), 10 mM
Experimental Procedures MgCl2, 10 mM NaCl, and 0.1 mM dithiothreitol at 37C for 1 hr. The
addition of 20 l of 2  SDS buffer terminated phosphorylation or
Materials dephosphorylation, and the reaction mixtures were analyzed by
Doxorubicin hydrochloride was obtained from Aldrich (USA), the SDS-PAGE.
96-well plate was coated with streptavidin, and NHS-biotin was
purchased from Pierce (USA). The T7 phage library displaying a Fluorescence and Biosensor Analysis
human liver cDNA library was purchased from Novagen (USA). Sen- Interaction between doxorubicin and protein was analyzed by fluo-
sor chip CM5 and the Amine Coupling Kit were obtained from Ap- rescence spectroscopy and biosensor analysis. The various con-
plied Biochem. (Sweden). All other reagents were of reagent grade. centrations of proteins were mixed with 0.7 M doxorubicin in 10
mM Mops (pH 7.5) containing 150 mM NaCl and 0.5 mM EDTA, and
the fluorescence spectra were measured with a LS50B Lumines-Immobilization of Doxorubicin and Biopanning
cence Spectrometer (Perkin Elmer). The excitation wavelength wasDoxorubicin was biotinylated after the incubation of 2 mM sulfo-
490 nm, and the emission spectra were obtained over the range ofNHS-biotin and 8 mM of doxorubicin in 50 mM sodium bicarbonate
530–600 nm.buffer (pH 8.0) at room temperature for 3 hr. Unreacted sulfo-NHS-
For biosensor analysis, doxorubicin was covalently linked to abiotin was inactivated by incubation in the presence of 50 mM gly-
CM5 sensor chip with the Amine Coupling Kit. The surface matrixcine (pH 8.0) for 1 hr. The mixture was then diluted 20-fold in PBS
was activated by a 10 min injection of an aqueous solution of 0.2 Mbuffer (20 mM sodium phosphate buffer [pH 7.5] 150 mM NaCl) and
N-ethyl-N-(3-diethylaminopropyl)-carbodiimide (EDC) and 50 mMtransferred to a well of the streptavidin-coated plate. After incuba-
N-hydroxysuccinimide (NHS). Then, 500 M doxorubicin in 30 l oftion for 1 hr at room temperature, the well was washed six times
10 mM sodium phosphate (pH 7.0) and 150 mM NaCl was injectedwith 0.1% Tween-20 solution in PBS buffer (PBST). The T7 phage
into the sensor cells. All coupling reactions were done at a flow ratelibrary of human liver cDNA (6  109 pfu) in 100 l of PBS buffer
of 5 l/min. Remaining N-hydroxysuccinimide-ester groups werewas added to the doxorubicin-attached plate, and the plate was
inactivated by injection of 1.0 M ethanolamine-HCl (pH 8.5) for 10incubated at room temperature for 40 min with gentle shaking. The
min. Protein samples in the running buffer (10 mM Mops (pH 7.5),plate was washed ten times with PBST, and phage particles that
150 mM NaCl, and 1 mM EDTA) were injected at a flow rate of 30adsorbed to the surface of the well were eluted after 30 min of
l/min. Association and dissociation curves were obtained on aincubation in the presence of 1% SDS. The eluted phage particles
BIAcore 3000 (ABI, USA). The surface of the sensor chip was regen-were amplified after infection into E. coli strain BLT5615 according
erated by injection of 10 l of the regeneration buffer (0.017% SDS,to the manufacturer’s instructions (Novagen). The amplified phage
30 mM NaCl, and 1.7 mM NaOH). The SPR response curves werewas applied to the streptavidin-coated plate primed with biotinyl-
analyzed with BIACORE EVALUATIONS software, version 3.1.ated doxorubicin. The phages that were bound to the surface were
eluted by the use of 1% SDS in the secibd round and 2.5 mM biotin
in the third and fourth rounds of biopanning. The biotin in the eluted Received: June 14, 2001
phage solution was not specifically removed because its concentra- Revised: October 1, 2001
tion was diluted to 5000-fold during the phage amplification proce- Accepted: October 2, 2001
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